Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3782343011 | Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3782344017 | 5-aminolevulinic acid-containing product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme cutanée | true | Inferred relationship | Some | ||
| Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form) | a pour principe actif (attribut) | acide 5-aminolévulinique | true | Inferred relationship | Some | 1 | |
| Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form) | est un(e) (attribut) | Product manufactured as cutaneous dose form (product) | true | Inferred relationship | Some | ||
| Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form) | est un(e) (attribut) | acide aminolévulinique | true | Inferred relationship | Some | ||
| Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| 5-aminolevulinic acid only product in cutaneous dose form | est un(e) (attribut) | True | Product containing 5-aminolevulinic acid in cutaneous dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR